Teva Pharmaceutical Industries Ltd

Latest stories

3d
Calcutta News
Takeover bid for Perrigo wins majority support of Mylan shareholders PITTSBURGH - Shareholders of Mylan N.V., a global pharmaceutical company, Fri
Takeover bid for Perrigo wins majority support of Mylan shareholders
Calcutta News / Posted 3 days ago
PITTSBURGH - Shareholders of Mylan N.V., a global pharmaceutical company, Friday overwhelmingly approved the company's $35.6 billion bid for Perrigo Company plc, giving a fillip to... Read more
16 related stories
3d
The Charleston State Journal
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) - Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
The Charleston State Journal / Posted 3 days ago
NEW YORK (AP) - Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
3d
Park Record
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
Park Record / Posted 3 days ago
NEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
3d
The Evening Sun
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
The Evening Sun / Posted 3 days ago
NEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
3d
New Jersey Herald
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) - Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
New Jersey Herald / Posted 3 days ago
NEW YORK (AP) - Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
3d
York Daily Record
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
York Daily Record / Posted 3 days ago
NEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
3d
Your Hometown Lima Stations
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) - Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
Your Hometown Lima Stations / Posted 3 days ago
NEW YORK (AP) - Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
3d
Carlsbad Current-Argus
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
Carlsbad Current-Argus / Posted 3 days ago
NEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
3d
KOB 4 Albuquerque
Mylan shareholders approve pursuit of PerrigoCreated: 08/28/2015 6:21 AM NEW YORK (AP) — Mylan NV's shareholders approved t
Mylan shareholders approve pursuit of Perrigo
KOB 4 Albuquerque / Posted 3 days ago
Created: 08/28/2015 6:21 AM NEW YORK (AP) — Mylan NV's shareholders approved the proposed buyout of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted... Read more
16 related stories
3d
Lebanon Daily News
Mylan shareholders approve pursuit of PerrigoNEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit
Mylan shareholders approve pursuit of Perrigo
Lebanon Daily News / Posted 3 days ago
NEW YORK (AP) — Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures... Read more
16 related stories
3d
Daily Herald
Mylan shareholders approve pursuit of PerrigoNEW YORK -- Mylan NV's shareholders approved the proposed buyout of Perrigo Co.
Mylan shareholders approve pursuit of Perrigo
Daily Herald / Posted 3 days ago
NEW YORK -- Mylan NV's shareholders approved the proposed buyout of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures from Mylan. A... Read more
16 related stories
3d
ABC News
Mylan Shareholders Approve Pursuit of PerrigoMylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. a
Mylan Shareholders Approve Pursuit of Perrigo
ABC News / Posted 3 days ago
Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon. Perrigo, which makes over-the-counter medicines, has resisted repeated overtures from Mylan. In a... Read more
16 related stories
4d
KPVI News 6 Pocatello
Federal court backs patent protecting Eli Lilly cancer drugINDIANAPOLIS — Shares of Eli Lilly rose Wednesday in premarket trading a day af
Federal court backs patent protecting Eli Lilly cancer drug
KPVI News 6 Pocatello / Posted 4 days ago
INDIANAPOLIS — Shares of Eli Lilly rose Wednesday in premarket trading a day after the drugmaker said a federal court upheld a patent protecting one of its top-selling drugs, the cancer treatment Alimta. The Indianapolis company said Tuesday after... Read more
3 related stories
5d
News 4 Reno
Federal court backs patent protecting Eli Lilly cancer drugINDIANAPOLIS — Shares of Eli Lilly rose Wednesday in premarket trading a day af
Federal court backs patent protecting Eli Lilly cancer drug
News 4 Reno / Posted 5 days ago
INDIANAPOLIS — Shares of Eli Lilly rose Wednesday in premarket trading a day after the drugmaker said a federal court upheld a patent protecting one of its top-selling drugs, the cancer treatment Alimta. The Indianapolis company said Tuesday after... Read more
3 related stories
5d
News 3 Las Vegas
Federal court backs patent protecting Eli Lilly cancer drugINDIANAPOLIS — Shares of Eli Lilly rose Wednesday in premarket trading a day af
Federal court backs patent protecting Eli Lilly cancer drug
News 3 Las Vegas / Posted 5 days ago
INDIANAPOLIS — Shares of Eli Lilly rose Wednesday in premarket trading a day after the drugmaker said a federal court upheld a patent protecting one of its top-selling drugs, the cancer treatment Alimta. The Indianapolis company said Tuesday after... Read more
3 related stories
5d
Fort Wayne News-Sentinel
Federal court backs patent protecting Eli Lilly cancer drugINDIANAPOLIS — Shares of Eli Lilly rose Wednesday in premarket trading a day af
Federal court backs patent protecting Eli Lilly cancer drug
Fort Wayne News-Sentinel / Posted 5 days ago
INDIANAPOLIS — Shares of Eli Lilly rose Wednesday in premarket trading a day after the drugmaker said a federal court upheld a patent protecting one of its top-selling drugs, the cancer treatment Alimta. The Indianapolis company said Tuesday after... Read more
3 related stories
20d
Business Insurance
Drugmaker prevails over comp insurers in off-label opioid caseThe U.S. District Court of Appeals for the 3rd Circuit has dismissed workers co
Drugmaker prevails over comp insurers in off-label opioid case
Business Insurance / Posted 20 days ago
The U.S. District Court of Appeals for the 3rd Circuit has dismissed workers compensation insurers' claims that a pharmaceutical company marketed its powerful opioids for off-label uses. Travelers Indemnity Co., Travelers Casualty & Surety Co.,... Read more
20d
Business Insurance
Drug maker prevails over comp insurers in off-label opioid caseThe U.S. District Court of Appeals for the 3rd Circuit has dismissed workers co
Drug maker prevails over comp insurers in off-label opioid case
Business Insurance / Posted 20 days ago
The U.S. District Court of Appeals for the 3rd Circuit has dismissed workers compensation insurers' claims that a pharmaceutical company marketed its powerful opioids for off-label uses. Travelers Indemnity Co., Travelers Casualty & Surety Co.,... Read more
25d
Market Watch
Patrick Drahi to move Altice to the NetherlandsEuropean telecom magnate Patrick Drahi prevailed Thursday in his effort to redo
Patrick Drahi to move Altice to the Netherlands
Market Watch / Posted 25 days ago
European telecom magnate Patrick Drahi prevailed Thursday in his effort to redomicile his Altice SA company in the Netherlands, part of an attempt to cement control even as he pursues potentially dilutive acquisitions across the globe. Shareholders... Read more
25d
Market Watch
Mylan raises outlook after stronger generic salesMylan NV on Thursday reported better-than-expected per-share earnings and raise
Mylan raises outlook after stronger generic sales
Market Watch / Posted 25 days ago
Mylan NV on Thursday reported better-than-expected per-share earnings and raised its outlook for the year, as the pharmaceutical company continues to try to buy Perrigo Co. Mylan has spent the past few months fending off takeover advances from Teva... Read more
5 related stories
25d
Channel NewsAsia
Allergan reports better-than-expected revenueREUTERS: Irish drugmaker Allergan Plc reported better-than-expected revenue for
Allergan reports better-than-expected revenue
Channel NewsAsia / Posted 25 days ago
REUTERS: Irish drugmaker Allergan Plc reported better-than-expected revenue for the first full quarter since the merger of Actavis and Allergan. Allergan, which changed its name from Actavis after the deal closed, said adding signature drugs like... Read more
5 related stories
25d
Channel NewsAsia
North America generic sales help Mylan's profit beatREUTERS: Drugmaker Mylan Inc reported a better-than-expected quarterly profit a
North America generic sales help Mylan's profit beat
Channel NewsAsia / Posted 25 days ago
REUTERS: Drugmaker Mylan Inc reported a better-than-expected quarterly profit as it sold more generic drugs in North America, and said it remained committed to its acquisition of Perrigo Co Plc. Mylan, which also raised its full-year earnings... Read more
25d
Channel NewsAsia
Allergan revenue more than doubles on Botox, eye drop salesREUTERS: Botox-maker Allergan Plc posted a better-than-expected quarterly adjus
Allergan revenue more than doubles on Botox, eye drop sales
Channel NewsAsia / Posted 25 days ago
REUTERS: Botox-maker Allergan Plc posted a better-than-expected quarterly adjusted profit as sales of branded drugs rose, helped by acquisition of new products. Branded drug sales jumped five-fold to US$3.71 billion in the second quarter ended June... Read more
5 related stories
25d
Market Watch
Allergan adjusted profit beats views as sales jumpAllergan PLC swung to a second-quarter loss on charges related to recent acquis
Allergan adjusted profit beats views as sales jump
Market Watch / Posted 25 days ago
Allergan PLC swung to a second-quarter loss on charges related to recent acquisitions and other one-time items. The results mark the first full quarter since Actavis PLC completed its roughly $66 billion deal for the maker of wrinkle treatment Botox... Read more
5 related stories
26d
TribLIVE
Roundup: Growth at U.S. services firms surges to record in July; Mazda recalls over 193,000 SUVs to fix front suspension; moreGrowth at services firms surges to record in July Business at American service
Roundup: Growth at U.S. services firms surges to record in July; Mazda recalls over 193,000 SUVs to fix front suspension; more
TribLIVE / Posted 26 days ago
Growth at services firms surges to record in July Business at American services companies surged in July, the Institute for Supply Management reported Wednesday. The institute said its services index rose to 60.3 last month, highest since the index... Read more
26d
Market Watch
Allergan changes $2.1 bln deal for Kythera to cashAllergan PLC amended the terms of its pending $2.1 billion deal for double-chin
Allergan changes $2.1 bln deal for Kythera to cash
Market Watch / Posted 26 days ago
Allergan PLC amended the terms of its pending $2.1 billion deal for double-chin treatment maker Kythera Biopharmaceuticals Inc. by agreeing to pay for it all in cash and dropping the stock component. In a news release Wednesday, the companies expect... Read more
5 related stories
26d
Market Watch
Perrigo revenue buoyed by branded health carePerrigo Co. said Wednesday that revenue grew more than expected in the June qua
Perrigo revenue buoyed by branded health care
Market Watch / Posted 26 days ago
Perrigo Co. said Wednesday that revenue grew more than expected in the June quarter because of its new branded consumer health-care segment and growth in pharmaceuticals. Shares, up 14% this year, increased less than 1% in premarket... Read more
m
TheBull
Amgen hikes 2015 forecast after 2Q liftAmgen Inc shares have jumped in extended trading after the maker of osteoporosi
Amgen hikes 2015 forecast after 2Q lift
TheBull / Posted 1 months ago
Amgen Inc shares have jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street's second-quarter profit expectations and raised its 2015 financial forecast. Amgen on Thursday said its net income rose to $US1.65... Read more
14 related stories
m
San Antonio Express-News
Amgen hikes 2015 forecast after 2Q increase in profit, salesTRENTON, N.J. (AP) — Amgen Inc. shares jumped in extended trading after the mak
Amgen hikes 2015 forecast after 2Q increase in profit, sales
San Antonio Express-News / Posted 1 months ago
TRENTON, N.J. (AP) — Amgen Inc. shares jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street's second-quarter profit expectations and hiked its 2015 financial forecast. Amgen, based in Thousand Oaks,... Read more
14 related stories
m
Chattanooga Times Free Press
Amgen hikes 2015 forecast after 2Q increase in profit, salesTRENTON, N.J. (AP) - Amgen Inc. shares jumped in extended trading after the mak
Amgen hikes 2015 forecast after 2Q increase in profit, sales
Chattanooga Times Free Press / Posted 1 months ago
TRENTON, N.J. (AP) - Amgen Inc. shares jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street's second-quarter profit expectations and hiked its 2015 financial forecast. Amgen, based in Thousand Oaks,... Read more
14 related stories
m
Salon.com
Amgen hikes 2015 forecast after 2Q increase in profit, salesTRENTON, N.J. (AP) — Amgen Inc. shares jumped in extended trading after the mak
Amgen hikes 2015 forecast after 2Q increase in profit, sales
Salon.com / Posted 1 months ago
TRENTON, N.J. (AP) — Amgen Inc. shares jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street’s second-quarter profit expectations and hiked its 2015 financial forecast. Amgen, based in Thousand Oaks,... Read more
14 related stories

People in this news